Will Pfizer Inc End Up Buying Bristol-Myers Squibb As Its Interest In AstraZeneca Fades?

Mergers and acquisitions (M&A)-related activity in the healthcare sector this year appears to be never-ending. Word on the Street now is that Pfizer Inc. (NYSE:PFE) may be looking into acquiring its New York-based neighbor, Bristol-Myers Squibb Co (NYSE:BMY).